Oramed Pharmaceuticals Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
28.67
|
|
Average Rating
|
4.80
|
|
# Strong Buys
|
4
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-02-28
|
-0.24
|
0.00
|
0.24
|
100.00%
|
|
2022-11-30
|
-0.17
|
-0.18
|
-0.01
|
-7.46%
|
|
2022-08-31
|
-0.25
|
-0.18
|
0.07
|
28.00%
|
|
2022-05-31
|
-0.22
|
-0.27
|
-0.05
|
-22.73%
|
|
2022-02-28
|
-0.23
|
-0.27
|
-0.04
|
-17.39%
|
|
2021-11-30
|
-0.16
|
-0.22
|
-0.06
|
-37.50%
|
|
2021-08-31
|
-0.18
|
-0.21
|
-0.03
|
-16.67%
|
|
2021-05-31
|
-0.20
|
-0.17
|
0.03
|
15.00%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-11-30
|
-0.18
|
|
2022-08-31
|
-0.94
|
|
2021-08-31
|
-0.78
|
|
2020-08-31
|
-0.58
|
|
2019-08-31
|
-0.82
|
|
2018-08-31
|
-0.86
|
|
2017-08-31
|
-0.79
|
|
2016-08-31
|
-0.87
|
|
2015-08-31
|
-0.68
|
|
2014-08-31
|
-0.61
|
|
2013-08-31
|
-0.59
|
|
2012-08-31
|
-0.57
|
|
2011-08-31
|
-0.31
|
|
2010-08-31
|
-0.63
|
|
2009-08-31
|
-0.59
|
|
2008-08-31
|
-0.39
|
|
2007-08-31
|
-0.92
|
|
2006-08-31
|
-0.14
|